Literature DB >> 14573818

Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity.

Angela Römer-Oberdörfer1, Ortrud Werner2, Jutta Veits1, Teshome Mebatsion3, Thomas C Mettenleiter1.   

Abstract

Newcastle disease virus (NDV) possesses two envelope spike glycoproteins: the haemagglutinin-neuraminidase (HN) protein and the fusion (F) protein. The HN protein, which is responsible for virus attachment to sialic acid-containing receptors, varies in length due to differences in the sizes of the ORFs. An HN protein precursor of 616 aa has been found in avirulent but not in virulent NDV strains, whereas an HN protein of 571 aa can be detected in highly virulent strains only. An HN protein of 577 aa is present in virulent and avirulent strains. The F protein, which mediates virus-cell fusion, requires proteolytic activation at an internal cleavage site, whose amino acid composition determines cleavability by various proteases. Here, the functional significance of the length of the HN protein in combination with F protein cleavage sites typical for virulent (velogenic and mesogenic) or avirulent (lentogenic) strains was investigated. To this end, site-directed mutagenesis was used to construct recombinant NDV on the basis of an infectious clone of the lentogenic vaccine virus Clone-30. Only recombinant NDV expressing an F protein with a multibasic cleavage site typical of virulent strains was able to spread efficiently in cell culture, irrespective of the size of the HN protein. Moreover, as determined by the intracerebral pathogenicity index (ICPI) in 1-day-old, specific-pathogen-free chickens, pathogenicity was influenced by the cleavability of the F protein and not by the length of the HN protein. The maximum ICPI value obtained for these recombinants was 1.3, as compared to a possible maximum of 2. This demonstrates that the modifications introduced did not result in the conversion of the lentogenic Clone-30 to a velogenic strain with an ICPI value of >1.5 and suggests the involvement of additional virulence determinants that contribute to the pathogenicity of NDV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573818     DOI: 10.1099/vir.0.19416-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  39 in total

1.  Detection of specific antigens of Newcastle disease virus using an absorbed Western blotting method.

Authors:  F Hemmatzadeh; M Kazemimanesh
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

2.  Antineoplastic activity of Newcastle disease virus strain D90 in oral squamous cell carcinoma.

Authors:  Chun-Xiao Zhang; Long-Wei Ye; Ying Liu; Xiao-Ya Xu; Dan-Rui Li; Yan-Qing Yang; Lu-Lu Sun; Jie Yuan
Journal:  Tumour Biol       Date:  2015-04-16

3.  Determination of organ tropism of Newcastle disease virus (strain I-2) by virus isolation and reverse transcription-polymerase chain reaction.

Authors:  P Wambura; J Meers; P Spradbrow
Journal:  Vet Res Commun       Date:  2006-08       Impact factor: 2.459

4.  Characterization of a recombinant Newcastle disease virus vaccine strain.

Authors:  Sun-Hee Cho; Hyuk-Joon Kwon; Tae-Eun Kim; Jae-Hong Kim; Han-Sang Yoo; Man-Hoon Park; Young-Ho Park; Sun-Joong Kim
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

5.  Autophagy benefits the replication of Newcastle disease virus in chicken cells and tissues.

Authors:  Yingjie Sun; Shengqing Yu; Na Ding; Chunchun Meng; Songshu Meng; Shilei Zhang; Yuan Zhan; Xusheng Qiu; Lei Tan; Hongjun Chen; Cuiping Song; Chan Ding
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

6.  Ubiquitous activation of the Nipah virus fusion protein does not require a basic amino acid at the cleavage site.

Authors:  Markus Moll; Sandra Diederich; Hans-Dieter Klenk; Markus Czub; Andrea Maisner
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Newcastle disease virus in Madagascar: identification of an original genotype possibly deriving from a died out ancestor of genotype IV.

Authors:  Olivier F Maminiaina; Patricia Gil; François-Xavier Briand; Emmanuel Albina; Djénéba Keita; Harentsoaniaina Rasamoelina Andriamanivo; Véronique Chevalier; Renaud Lancelot; Dominique Martinez; R Rakotondravao; Jean-Joseph Rajaonarison; M Koko; Abel A Andriantsimahavandy; Véronique Jestin; Renata Servan de Almeida
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

8.  Nucleotide and predicted amino acid sequence analysis of the fusion protein and hemagglutinin-neuraminidase protein genes among Newcastle disease virus isolates. Phylogenetic relationships among the Paramyxovirinae based on attachment glycoprotein sequences.

Authors:  Bruce S Seal
Journal:  Funct Integr Genomics       Date:  2004-04-24       Impact factor: 3.410

9.  Role of C596 in the C-terminal extension of the haemagglutinin-neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus.

Authors:  Shin-Hee Kim; Sa Xiao; Anandan Paldurai; Peter L Collins; Siba K Samal
Journal:  J Gen Virol       Date:  2013-11-06       Impact factor: 3.891

10.  Genomic comparison of the complete coding and intergenic regions of the VG/GA Newcastle disease virus and its respirotropic clone 5.

Authors:  Francisco Perozo; Pedro Villegas; Claudio L Afonso
Journal:  Virus Genes       Date:  2008-06-24       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.